CompletedNCT01419158

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Alpha-1 Foundation
Principal Investigator: Robert A Sandhaus, M.D., Ph.D.
National Jewish Health
Enrollment: 3457 enrolled
Eligibility: 18 years · All sexes
Timeline: 2008 – 2010

Study locations (19)

University of California Los Angeles, Los Angeles, California, United States
National Jewish Medical and Research Center, Denver, Colorado, United States
University of Florida (Gainesville), Gainesville, Florida, United States
University of Florida (Jacksonville), Jacksonville, Florida, United States
University of Miami, Miami, Florida, United States
Miami VA Medical Center, Miami, Florida, United States
Cleveland Clinic Florida, Weston, Florida, United States
Emory Crawford Long Hospital, Atlanta, Georgia, United States
Emory University, Atlanta, Georgia, United States
Atlanta VA Medical Center, Decatur, Georgia, United States
University of Chicago, Chicago, Illinois, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
St. Luke's-Roosevelt Hospital Center, New York, New York, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
+4 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01419158 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency →

← Back to all trials